Search results for: “biopharmaceutical”
-
AbCellera Biologics acquires Trianni Inc. for $90 million
•
VANCOUVER: AbCellera Biologics has acquired Trianni Inc. in an all-cash transaction valued at US$90 million, a news release…
-
Sumitovant Biopharma will acquire Urovant Sciences for $584 million
•
IRVINE: Urovant Sciences has entered into a definitive agreement in which Sumitovant Biopharma will acquire Urovant Sciences for…
-
AstraZeneca’s Forxiga approved in the EU for heart failure
•
LONDON, UK: AstraZeneca‘s Forxiga (dapagliflozin) has been approved in the European Union (EU) for the treatment of symptomatic…
-
Lonza Welcomes New Group Chief Executive Officer Pierre-Alain Ruffieux
•
BASEL: Pierre-Alain Ruffieux today joins Lonza Group in the role of Chief Executive Officer, a news release said.…
-
AstraZeneca agrees to sell commercial rights to Atacand to Cheplapharm Arzneimittel GmbH
•
LONDON: AstraZeneca has agreed to sell the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (a fixed-dose…
-
Takeda to import and distribute 50 million doses of Moderna’s COVID-19 vaccine in Japan
•
OSAKA: Takeda Pharmaceutical Company Limited will import and distribute 50 million doses of Moderna’s COVID-19 vaccine candidate, mRNA-1273,…
-
Canntab to launch in Australia and participate in Australia’s largest cannabis research
•
TORONTO: Canntab Therapeutics Limited announced the impending launch of its suite of hard pill cannabinoid formulations in Australia…
-
AbbVie Inc.
•
AbbVie Inc. is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of…
-
BELLUS Health announces launch of a public shares offering in Canada and the United States
•
LAVAL, QUEBEC: BELLUS Health Inc. announced the filing of a preliminary prospectus supplement in connection with a proposed…
-
Tarsus Pharmaceuticals prices $88 million IPO on Nasdaq Global Market
•
LONDON: RTW Venture Fund Limited’s portfolio company Tarsus Pharmaceuticals Inc. has priced an $88 million initial public offering…
-
Oncimmune signs agreement with Cedars-Sinai to profile immune response to COVID-19
•
LONDON: Oncimmune Holdings plc has signed a commercial agreement with Cedars-Sinai, California, USA, to provide antibody profiling in…
-
Ovoca Bio appoints Christopher Wiltshire as Chief Business Officer
•
DUBLIN: Ovoca Bio, a biopharmaceutical company with a focus on women’s health, announced the appointment of Christopher Wiltshire…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.